Author: Margaret Moses Branch
Yaz Investigated For Increased Risk Of Blood Clots
Many types of birth control pills create risks of blood clots. However, new birth control research suggests that certain types of pills create an even higher risk of blood clots than others. Birth control pills that contain Drospirenone – such as Yaz, Yasmin, and Beyaz contain a two to three-time higher risk for developing blot… read more
Zimmer Introduces New Tool For Use In Defective Knee Revision Surgeries
Zimmer Holdings – maker of the defective Zimmer NexGen knee replacements – has recently announced that it has developed a complete set of Trabecular Metal material augmented shapes and cones to be used in knee revision surgeries. These new augments are intended to fill any size bone defects detected while performing surgery and supposed to… read more
Topamax May Alter Effectiveness Of Birth Control Pills
Recent reports indicate that in addition to problems such as cleft palates and cleft lip from taking Topamax, Topamax may cause oral contraceptives to lose their effectiveness. Topamax (topiramate) is a popular migraine and seizure medication that has been recently revised by the FDA as a “Class D” pregnancy drug – i.e. one where significant… read more
Topamax Recall After Reports Of Unusual Odors
Johnson & Johnson has issued a Topamax recall after receiving complaints about an unusual odor linked to a byproduct from a chemical used in treating wood. Sources believe the contamination may have occurred as a result of the way medication is shipped and stored. Topamax has recently come under fire after the FDA issued warnings… read more
Senate To Begin Investigation Of DePuy Hip Safety
This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA’s role in “protecting patient safety as part of the medical device approval process.” The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement… read more
Zimmer NexGen Knee Recall Urged Due To Component Problems
Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that… read more
FDA Removes 500 Unapproved Prescription Drugs From The Market
The FDA has announced that it will be seeking to remove nearly 500 unapproved prescription drugs from the market. In a statement, the director of compliance at the Center for Drug Evaluation and Research notes that they “don’t know what’s in them, whether they work properly, or how they are made.” If believe you may… read more
Topamax Linked To Birth Defects
The New York Times reports that Topamax, manufactured by Johnson & Johnson, has been linked to birth defects, such as a higher risk of developing cleft lips and palates, genital malformations, and cranial malformations. Topamax is an anti-seizure and migraine drug used in the treatment of migraines and epilepsy. It is also used in the… read more
Medical Malpractice Reform Should Focus On Patient Safety
Medical Malpractice reform has been receiving much attention recently with the introduction of H.R. 5, which seeks to impose national tort reform measures, including the imposition of caps on non-economic damages as well as potentially taking away the right to trial by jury in some medical malpractice cases. As New Mexico medical malpractice lawyers, we… read more
New Mexico Corporation Settles Nursing Home Negligence Case For $3.5 Million
A recent news report indicates that a New Mexico Corporation, Sunbridge Health Court Corp., has reached a settlement in a nursing home negligence case for $3.5 million. If you believe a loved one has suffered from nursing home abuse, you need an experienced Albuquerque nursing home abuse lawyer. The lawsuit was filed in 2009 alleging… read more